Efficacy and safety of larotrectinib in patients with non-primary central nervous system TRK fusion cancer: An updated analysis.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Rui-Hua Xu, David S. Hong, Cornelis Martinus van Tilburg, Daniel Orbach, Daniel Shao-Weng Tan, Jessica Jiyeong Lin, Birgit Geoerger, Antoine Italiano, Shivaani Kummar, Ulrik Niels Lassen, Raymond S. McDermott, Domnita-Ileana Burcoveanu, Nicoletta Brega, Natascha Neu, Theodore Willis Laetsch, Changsong Qi, Alexander E. Drilon
Institutions: Sun Yat-sen University Cancer Center, The University of Texas MD Anderson Cancer Center, German Cancer Research Center, University Hospital Heidelberg, Hopp Children's Cancer Center Heidelberg, Université Paris Sciences et Lettres, Institut Curie, National University of Singapore, Duke-NUS Medical School, National Cancer Centre Singapore, Harvard University, Massachusetts General Hospital, Inserm, Université Paris-Saclay, Institut Gustave Roussy, Université de Bordeaux, Oregon Health & Science University, Rigshospitalet, Cancer Trials Ireland, St. Vincent's University Hospital, Bayer (Switzerland), Bayer (Italy), Children's Hospital of Philadelphia, University of Pennsylvania, Peking University Cancer Hospital, Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410822787